Use of Checkpoint Inhibitors in Gray Zone Lymphoma
2020 · Hematology/Oncology and Stem Cell Therapy · 6 citations
https://doi.org/10.1016/j.hemonc.2020.06.001
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
269
Citations
7
h-index
7
i10-index
Francisco Dário Rocha Filho is an academic researcher from Universidade Federal do Ceará. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research. The author has an h-index of 7, co-authored 28 publications.
ORCID: 0000-0003-2189-3752https://doi.org/10.1016/j.hemonc.2020.06.001
https://doi.org/10.1590/s1516-84842008000500020
https://doi.org/10.1590/s1516-84842003000100006
Click to start Chat